Health TrialsbyHealthPanel

Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in France

ConditionGenetic and Inflammatory Polyneuropathies
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

To describe the clinical, electrophysiological, and genetic characteristics of patients with genetic and inflammatory polyneuropathies in France.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients aged 18 years or older.

Patients with a diagnosis of genetic or inflammatory polyneuropathy, confirmed by complementary examinations performed as part of routine care, including genetic, biological and/or electrophysiological tests.

Disqualifiers

None

Trial population

Adults diagnosed with genetic or inflammatory polyneuropathy and followed in participating neurology centers in France.

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Number and percentage of participants by type of polyneuropathy

Participants will be classified as having genetic or inflammatory polyneuropathy according to the diagnosis documented in their medical records. The number and percentage of participants in each category will be reported.

Time frame
At inclusion, based on the diagnosis documented in the medical record.

Secondary outcomes

1

Number and percentage of participants by polyneuropathy subtype

The number and percentage of participants in each genetic or inflammatory polyneuropathy subtype, as documented in the medical records, will be reported.

Time frame
At inclusion, based on the diagnosis documented in the medical record.
2

Demographic characteristics of patients

Description of demographic characteristics of patients with genetic or inflammatory polyneuropathies, including age, sex and other available demographic data.

Time frame
At baseline, corresponding to the date of inclusion in the study, using data available in the medical record up to that date.
3

Geographical distribution of patients

Description of the geographical distribution of patients with genetic or inflammatory polyneuropathies included in participating centers in France.

Time frame
At baseline, corresponding to the date of inclusion in the study, using data available in the medical record up to that date.
4

Number and percentage of participants by electrophysiological neuropathy pattern

The electrophysiological neuropathy pattern documented in the medical record will be classified as axonal, demyelinating or mixed. The number and percentage of participants in each category will be reported.

Time frame
At inclusion, based on electrophysiological examinations available in the medical record.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assistance Publique - Hôpitaux de Paris

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: